Skip to content

Randomized Controlled Trial Assessing the Effect of Dexamethasone on Postoperative Function After Distal Radius Fixation

Randomized Controlled Trial Assessing the Effect of Intraoperative Dexamethasone in the Management of Postoperative Analgesia and Stiffness After Distal Radius Fixation

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04889547
Enrollment
70
Registered
2021-05-17
Start date
2021-07-10
Completion date
2023-09-01
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Radius Fracture

Brief summary

The study is designed to assess the use of intraoperative dexamethasone on postoperative analgesia and stiffness after open reduction and internal fixation of distal radius fractures. The idea is that the dexamethasone will aid in reducing postoperative swelling which will then improve pain control as well as overall function.

Interventions

DRUGDexamethasone

Intraoperative intravenous dexamethasone

No intraoperative intravenous dexamethasone

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Provision of signed and dated informed consent form * Willingness to comply with study procedures and * Male or female greater than 18 years old * American Society of Anesthesia class I/II/III * Ability to take oral medicine in order to assess opioid regimen postop * Distal radius open reduction and internal fixation surgery with single incision and volar plate * Ability to consent for and receive a preoperative upper extremity nerve block by anesthesia

Exclusion criteria

* Chronic opioid users * Prescriptions for selective-serotonin reuptake inhibitors, gabapentin, duloxetine within 3 days of surgery * History of diabetes and A1C \> 8 * Systemic glucocorticoids within 1 month of study enrollment * Inability to take ibuprofen or acetaminophen due to allergy or condition * History of hepatitis * Pregnancy or lactation * Allergic to opioids * Known allergic reactions to components of IV dexamethasone

Design outcomes

Primary

MeasureTime frameDescription
Patient rated wrist evaluation48 hours, 1 week, 2 weeks15-item questionnaire designed to measure wrist pain and disability in activities of daily living. PWRE will be assessed at multiple time point to assess for change in the score. The higher the score, the more function exhibited.

Secondary

MeasureTime frameDescription
Finger-to-palm distance48 hours, 1 week, 2 weeksObjective measure to quantify stiffness. This is measured by measuring the distance from the tip of the third finger to the palm during attempted creation of a fist. FTP will be measured at multiple time points to assess for change.
Visual analog scale48 hours, 1 week, 2 weeksValidated, subjective measure for pain. Measured on a 10 point scale, 0 being no pain and 10 being maximum pain. VAS will be evaluated at multiple time points to assess for change.
Total opioid consumption48 hours, 1 week, 2 weeksMeasuring total opioid consumption postoperatively. This will be measured by self reported mechanism. Assessed at multiple time points to assess for change.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026